Official Title
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
Brief Summary

The study is a double-blind, randomized, placebo-controlled, multi-center, Phase 3 study to evaluate the efficacy and safety of fostamatinib in COVID-19 subjects.

Detailed Description

The primary objective of this study is:

To evaluate the efficacy of fostamatinib when used in combination with standard of care (SOC)
in subjects hospitalized with COVID- 19 and requiring oxygen supplementation, as measured by
days on oxygen.

Completed
COVID19
SARS (Severe Acute Respiratory Syndrome)
SARS Pneumonia
SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
Pneumonia
Pneumonia, Viral

Drug: Fostamatinib

Fostamatinib (150 mg twice daily) for 14 days and Standard of Care
Other Name: Fostamatinib disodium

Drug: Placebo

Placebo (twice daily) for 14 days and Standard of Care

Eligibility Criteria

Inclusion Criteria:

- ≥18 years of age at screening.

- The subject or a legally authorized representative has provided written informed
consent.

- Hospitalized COVID-19 subjects without respiratory failure who are either not
receiving any oxygen therapy or are receiving supplemental oxygen via mask or nasal
prongs.

- Male or non-pregnant, non-lactating female subjects with SARS-CoV-2 infection
documented by a hospital approved diagnostic test (eg, a Food and Drug Administration
authorized test in the US) within 7 days prior to randomization.

Exclusion Criteria:

- Pregnant or lactating female of childbearing potential.

- Use of extracorporeal membrane oxygenation (ECMO).

- Uncontrolled hypertension (systolic blood pressure [BP] ≥160 mmHg and/or diastolic BP
≥100 mmHg), unstable angina, congestive heart failure of New York Heart Association
classification III or IV, serious cardiac arrhythmia requiring treatment at screening.

- History of myocardial infarction within 1 month prior to screening.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 100 Years
Countries
Argentina
Brazil
Mexico
United States
Locations

University of California Irvine
Orange, California, United States

George Washington University Hospital
Washington, District of Columbia, United States

Alternative Research Associates, LLC
Hialeah, Florida, United States

Alternative Research Associates, LLC
Miami, Florida, United States

Loyola University Medical School
Maywood, Illinois, United States

Harvard Medical School- Bringham and Women's Hospital
Boston, Massachusetts, United States

Henry Ford
Detroit, Michigan, United States

Ascension Medical Group- St. John Clinic Infectious Disease
Tulsa, Oklahoma, United States

Houston Methodist Research Institute
Houston, Texas, United States

Clinica Chutro
Cordoba, CP, Argentina

Hospital Lencinas
Godoy Cruz, Mendoza, Argentina

Corporacion Medica de General San Martin
San Martin, Provincia De Buenos Aires, Argentina

Hospital de Alta Complejidad Cuenta Alta
Buenos Aires, Argentina

Hospital Del Bicentenario - Dr. Luis Federico Leloir
Buenos Aires, Argentina

Clinica Zabala
Buenos Aires, Argentina

Clinica Adventista Belgrano
Buenos Aires, Argentina

Clinica Monte Grande
Buenos Aires, Argentina

Hospital de Infecciosas Dr.Francisco Javier Muñiz
Buenos Aires, Argentina

Sanatorio Guemes
Buenos Aires, Argentina

Sanatorio Sagrado Corazon
Buenos Aires, Argentina

Hospital San Roque
Córdoba, Argentina

Sanatorio Mayo Privado
Córdoba, Argentina

Hospital das Clínicas da Universidade Federal de Goiás (HC/UFG)
Goiânia, Goiás, Brazil

Hospital Luxenburgo-Associação Mário Penna
Belo Horizonte, Minas Gerais, Brazil

Hospital Universitario de Maringa
Maringá, Parana, Brazil

Hosp. Angelina Caron
Campina Grande do Sul, Paraná, Brazil

Irmandade da Santa Casa de Misericórdia de Porto Alegre - ISCMPA
Porto Alegre, Rio Grande Do Sul, Brazil

Hospital des clinicas de porto alegre - Centro de pequisas clinicas
Porto Alegre,, RS, Brazil

Complexo de Prevenção, Diagnóstico, Terapia e Reabilitação Respiratória LTDA
Blumenau, Santa Catarina, Brazil

Hospital Alemão Oswaldo Cruz (HAOC)
Bela Vista, Sao Paolo, Brazil

Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP)
Campinas, Sao Paolo, Brazil

Hospital Bandeirantes (LeForte)
Liberdade, Sao Paolo, Brazil

Hospital Universitário São Francisco na Providência de Deus
Braganca Paulista, Sao Paulo, Brazil

Clinica de Alergia Martti Antila S/S Ltda
Sorocaba, Sao Paulo, Brazil

Fundação Faculdade Reg. de Med de SJRP
São José Do Rio Preto, Sao Paulo, Brazil

Star Medica Vivo Bicentenario
Nezahualcóyotl, Mex, Mexico

Unidad Medica para la Salud Integral (UMSI)
Monterrey, Nuevo Leon, Mexico

Köhler & Milstein Research
Mérida, Yucatán, Mexico

Hospital Cardiologica Aguascalientes
Aguascalientes, Mexico

Icaro Investigaciones en Medicina
Chihuahua, Mexico

Nuevo Hospital Civil de Guadalajara
Guadalajara, Mexico

Centro Medico Issemym Toluca
Metepec, Mexico

The American British Cowdray Medical Center I.A.P.
Mexico City, Mexico

Hospital Ángeles Roma
Mexico, Mexico

CEPREP Centro de Prevención y Rehabilitación de Enfermedades Pulmonares Crónicas
Nuevo León, Mexico

Hospital Civil de Culiacan
Sinaloa, Mexico

Hospital Civil de Culiacan
Sinaloa, Mexico

Rigel Pharmaceuticals
NCT Number
Keywords
COVID19
SARS-Associated Coronavirus Pneumonia
Pneumonia, viral
MeSH Terms
COVID-19
Pneumonia
Coronavirus Infections
Severe Acute Respiratory Syndrome
Pneumonia, Viral